Skip to main content
Top

05-04-2018 | Gestational diabetes | Article

The post-HAPO situation with gestational diabetes: the bright and dark sides

Journal: Acta Diabetologica

Authors: Annunziata Lapolla, Boyd E. Metzger

Publisher: Springer Milan

Abstract

Aim

In 2010, in light of the data coming from the HAPO study, the International Association of Diabetes and Pregnancy Study Groups (IADPSG) proposed a new detection strategy and diagnostic criteria for gestational diabetes based on a one-step approach with a 75 g OGTT. This review analyzes and discusses the bright and dark sides of their application.

Methods

The assessment of these recommendations by the international organizations involved in the care of gestational diabetes and a series of observational, retrospective and prospective studies that have been published since 2010 regarding the use of the IADPSG recommendations have been evaluated.

Results

The different international associations involved in the care of pregnancy and of pregnancy complicated by diabetes have not taken an univocal position some of which have accepted them, while others have criticized them. Then, the actual application of the approach recommended by the IADPSG for detecting and diagnosing GDM varies, even at centers that reportedly accept the new diagnostic criteria.

Conclusion

So the challenge lies in making every effort to achieve a global standardization of the strategies for detecting, diagnosing and treating GDM.
Literature
1.
American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29(suppl 1):S43–S48
2.
Lapolla A, Dalfrà MG, Bonomo M et al (2009) Gestational diabetes mellitus in Italy: a multicenter study. Eur J Obstet Gynecol Reprod Biol 145(2):149–153CrossRefPubMed
3.
Metzger BE, Lowe P, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. New Engl J Med 38:1991–2002
4.
Kim C, Newton KM, Knoop RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes care 25:1862–1868CrossRefPubMed
5.
O’Sullivan JB, Mahan C (1964) Criteria for oral glucose tolerance test in pregnancy. Diabetes 13:436–440CrossRef
6.
Sermer M, Naylor CD, Gare DJ et al (1995) Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. Am J Obstet Gynecol 173:146–156CrossRefPubMed
7.
Jensen DM, Damm P, Sørensen B et al (2001) Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 185:413–419CrossRefPubMed
8.
Vambergue A, Nuttens MC, Verier-Mine O et al (2000) Is mild gestational hyperglycaemia associated with maternal and neonatal complications? The Diagest Study. Diabet Med 17:203–208CrossRefPubMed
9.
Lapolla A, Dalfrà MG, Bonomo M et al (2007) Can plasma glucose and HbA1c predict fetal growth in mothers with different glucose tolerance levels? Diabetes Res Clin Pract 77(3):465–470CrossRefPubMed
10.
Lapolla A, Bonomo M, Dalfrà MG et al (2010) Prepregnancy BMI influences maternal and fetal outcomes in women with isolated gestational hyperglycaemia: a multicentre study. Diabetes Metab 36(4):265–270CrossRefPubMed
11.
HAPO Study Cooperative Research Group, Metzger BE, Lowe LP et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2001CrossRef
12.
Crowther CA, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486CrossRefPubMed
13.
Landon MB, Spong CY, Thom E et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361:1339–1348CrossRefPubMedPubMedCentral
14.
Schmidt MI, Duncan BB, Reichelt AJ et al (2001) gestational diabetes mellitus diagnosed with 75 gr glucose tolerance test and adverse pregnancy outcome. Diabetes Care 24:1151–1115CrossRefPubMed
15.
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682CrossRefPubMedCentral
16.
Committee Opinion Number 504, American College of Obstetricians and Gynecologists (2011) Screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 118:751–753CrossRef
17.
Ryan EA (2011) Diagnosis of gestational diabetes. Diabetologia 54:480–486CrossRefPubMedPubMedCentral
18.
Long H (2011) Diagnosis of gestational diabetes: can expert opinion replace scientific evidence? Diabetologia 54:2211–2213CrossRefPubMed
19.
Long H, Cundy T (2013) Establishing consensus in the diagnosis of gestational diabetes following HAPO: were do we stand? Curr Diab Res 13:43–50CrossRef
20.
McIntire HD, Metzger BE, Coustan DR et al (2014) Counterpoint: establishing consensus in the diagnosis of gestational diabetes following the HAPO study. Curr Diab Res 14:497–454CrossRef
21.
Sacks DA, Hadden DR, Deerochanawong C et al (2012) Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Diabetes Care 35:526–528CrossRefPubMedPubMedCentral
22.
Duran A, Saenz S, Torrejon MJ et al (2014) Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnancy woman: the St. Carlos Gestational Diabetes Study. Diabetes Care 37:2442–2450CrossRefPubMed
23.
Lapolla A, Dalfrà MG, Ragazzi E et al (2011) New International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations for diagnosing gestational diabetes compared with former criteria: a retrospective study on pregnancy outcome. Diabet Med 28(9):1074–1077CrossRefPubMed
24.
Wery E, Vambergue A, Le Goueff F et al (2014) Impact of the new screening criteria on the gestational diabetes prevalence. J Gynecol Obstet Biol Reprod 43(4):307–313CrossRef
25.
Mayo K, Melamed N, Vandenberghe H et al (2105) The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes. Am J Obstet Gynecol 212(2):224–228
26.
Kong JM, Lim K, Thompson DM (2015) Evaluation of the International Association of the Diabetes In Pregnancy Study Group new criteria: gestational diabetes project. Can J Diabetes 39(2):128–132CrossRefPubMed
27.
Feldman RK, Tieu RS, Yasumura L (2016) Gestational diabetes screening: the international association of the diabetes and pregnancy study groups compared with Carpenter–Coustan screening. Obstet Gynecol 127(1):10–17CrossRef
28.
Ogunleye OK, Davidson KD, Gregg AR, Egerman RS (2017) Perinatal outcomes after adopting 1- versus 2-step approach to diagnosing gestational diabetes. J Matern Fetal Neonatal Med 30(2):186–190CrossRefPubMed
29.
Avalos GE, Owens LA, Dunne F, ATLANTIC DIP Collaborators (2013) Applying current screening tools for gestational diabetes mellitus to a European population: is it time for change? Diabetes Care 36(10):3040–3044CrossRefPubMedPubMedCentral
30.
Donovan LE, Edwards AL, Savu A et al (2017) Population-level Outcomes with a 2-step approach for gestational diabetes screening and diagnosis. Can J Diabetes. https://​doi.​org/​10.​1016/​j.​jcjd.​2016.​12.​010 CrossRefPubMed
31.
Sacks DA, Black MH, Li X, Montoro MN, Lawrence JM (2016) Adverse pregnancy outcomes using the international association of the diabetes and pregnancy study groups criteria: glycemic thresholds and associated risks. Obstet Gynecol 126(1):67–73CrossRef
32.
Waters TP, Dyer AR, Scholtens DM et al (2016) Maternal and neonatal morbidity for woman who would be added to the diagnosis of GDM using IADPSG criteria: a secondary analysis of the hyperglycemia and adverse pregnancy outcome study. Diabetes Care 39:2204–2210CrossRefPubMedPubMedCentral
33.
Mission JF, Ohno MS, Cheng YW, Caughey AB (2012) Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol 207:326.e1–326.e9CrossRef
34.
Werner EF, Pettker CM, Zuckerwise L et al (2012) Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care 35(3):529–535CrossRef
35.
Marseille E, Lohse N, Jiwani A et al (2013) The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med 26(8):802–810CrossRefPubMed
36.
Moses RG, Morris GJ, Petocz P, SanGil F (2011) The impact of potential new diagnostic criteria on the prevalence of gestational diabetes mellitus in Australia. Med J Aust 194(7):338–340PubMed
37.
Agarwal MM, Dhatt GS, Othman Y (2015) Gestational diabetes: differences between the current international diagnostic criteria and implications of switching to IADPSG. J Diabetes Compl 29(4):544–549CrossRef
38.
Kalter-Leibovici O, Freedman LS, Olmer L, Lieberman N, Heymann A, Orna T, Lerner-Geva L, Hod M (2012) Screening and diagnosis of gestational diabetes mellitus. Diabetes Care 35:1894–1896CrossRefPubMedPubMedCentral
39.
Savona-Ventura C, Vassallo J, Marre M, Karamanos BG; MGSD-GDM study group (2013) A composite risk assessment model to screen for gestational diabetes mellitus among Mediterranean women. Int J Gynaecol Obstet 120(3):240–244CrossRefPubMed
40.
Yeral MI, Ozgu-Erdinc AS, Uygur D et al (2014) Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine 46(3):512–518CrossRefPubMed
41.
Poomalar GK, Rangaswamy V (2013) A comparison of fasting plasma glucose and glucose challenge test for screening of gestational diabetes mellitus. J Obstet Gynaecol 33(5):447–450CrossRefPubMed
42.
Ozgu-Erdinc AS, Yilmaz S, Yeral MI et al (2015) Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices. J Matern Fetal Neonatal Med 28(16):1957–1962CrossRefPubMed
43.
Wang C, Zhu W, Wei Y et al (2016) The predictive effects of early pregnancy lipid profiles and fasting glucose on the risk of gestational diabetes mellitus stratified by body mass index. J Diabetes Res 2016:3013357
44.
Agarwal MM (2016) Gestational diabetes mellitus: screening with fasting plasma glucose. World J Diabetes 7:279–289CrossRefPubMedPubMedCentral
45.
Agarwal MM, Dhatt GS, Punnose J, Zayed R (2007) Gestational diabetes: fasting and postprandial glucose as first prenatal screening tests in a high-risk population. J Reprod Med 52(4):299–305PubMed
46.
Corrado F, D’Anna R, Cannata ML et al (2012) Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes Metab 38(5):458–461CrossRefPubMed
47.
Riskin-Mashiah S, Damti A, Younes G, Auslender R (2010) First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 152(2):163–167CrossRefPubMed
48.
Zhu WW, Yang HX, Wei YM et al (2013) Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care 36(3):586–590CrossRefPubMedPubMedCentral
49.
Popova P, Tkachuk A, Dronova A et al (2016) Fasting glycemia at the first prenatal visit and pregnancy outcomes in Russian women. Minerva Endocrinol 41(4):477–485PubMed
50.
Jiwani A, Marseille E, Lohse N et al (2012) Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 25:600–610CrossRefPubMed
51.
Buckley BS, Harreiter J, Damm P et al (2012) Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med 29:844–854CrossRefPubMed
52.
Pintaudi B, Fresa R, Dalfrà M et al (2016) Level of implementation of guidelines on screening and diagnosis of gestational diabetes: a national survey. Diabetes Res Clin Pract 113:48–52CrossRefPubMed
53.
WHO (2013) Diagnostic criteria and classification of hyperglycemia first detected in pregnancy. World Health Organization, Geneva
54.
ACOG (2011) Committee opinion no. 504: screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 18(3):751–753
55.
Benhalima K, Van Crombrugge P, Devlieger R et al (2013) Screening for pregestational and gestational diabetes in pregnancy: a survey of obstetrical centers in the northern part of Belgium. Diabetol Metab Syndr 5:66–70CrossRefPubMedPubMedCentral
56.
American Diabetes Association (2017) Standard of medical care in diabetes. Gestational diabetes mellitus. Diabetes Care 40(1):S11–S24CrossRef
57.
NICE Guidelines (2015) Diabetes in pregnancy: management from preconception to the postnatal period. https://​www.​nice.​org.​uk/​guidance.​ng3
58.
Di CianniG, Gualdani E, Berni C, Meucci A, Roti L, Lencioni C, Lacaria E, Seghieri G, Francesconi P (2017) Screening for gestational diabetes in Tuscany, Italy. A population study. Diab Res Clin pract 132:149–156CrossRef
59.
Nielsen KK, De Courten M, Kapur A (2012) The urgent need for universally applicable simple screening procedures and diagnostic criteria for gestational diabetes mellitus-lessons from projects funded by the World Diabetes Foundation. Global Health Action 5:1–12CrossRef
60.
Agarwal MM, Shah SM, Al Kaabi J, Saquib S, Othman Y (2015) Gestational diabetes mellitus: Confusion among medical doctors caused by multiple international criteria. J Obstet Gynaecol Res 41(6):861–869CrossRefPubMed
61.
Hod M, Kapur A, Sacks DA et al (2015) The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 131(Suppl 3):S173–S211CrossRefPubMed

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »